Jove
Visualize
Contact Us

Related Experiment Videos

Polyunsaturated fatty acid supplementation in MS.

T M Stewart1, A C Bowling

  • 1Complementary and Alternative Medicine Program, Rocky Mountain Multiple Sclerosis Center, Englewood, Colorado 80113, USA.

International MS Journal
|January 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of a Novel Substrate-Derived Spermine Oxidase Inhibitor.

Acta naturae·2020
Same author

Endobronchial cuff leak: case report of a temporising measure.

Anaesthesia and intensive care·2017
Same author

Moderators and Predictors of Response to Eating Disorder Risk Factor Reduction Programs in Collegiate Female Athletes.

Psychology of sport and exercise·2014
Same author

Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy Phase 2 (CALERIE Phase 2) screening and recruitment: methods and results.

Contemporary clinical trials·2012
Same author

Recruitment bias in studies of semen and other factors affecting pregnancy rates in fertile men.

Human reproduction (Oxford, England)·2009
Same author

Associations between andrological measures, hormones and semen quality in fertile Australian men: inverse relationship between obesity and sperm output.

Human reproduction (Oxford, England)·2009
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Polyunsaturated fatty acid (PUFA) supplements are popular for multiple sclerosis (MS) but require more research. While generally safe and showing some benefits, specific PUFA types and patient conditions warrant caution.

Area of Science:

  • Neurology
  • Nutritional Science
  • Complementary and Alternative Medicine

Background:

  • Polyunsaturated fatty acid (PUFA) supplementation is a common complementary and alternative therapy for multiple sclerosis (MS).
  • Clinicians need to be aware of available PUFA supplements and their associated efficacy and safety data.
  • Existing small-scale studies indicate potential beneficial effects of PUFA supplementation in MS.

Purpose of the Study:

  • To review the efficacy and safety data of polyunsaturated fatty acid (PUFA) supplementation for multiple sclerosis (MS).
  • To inform clinicians about the current evidence regarding PUFA supplements for MS patients.

Main Methods:

  • Systematic review of clinical studies on PUFA supplementation in multiple sclerosis.
  • Analysis of efficacy and safety data from available research.

Related Experiment Videos

Main Results:

  • Small-scale studies suggest a trend towards beneficial effects from PUFA supplementation.
  • PUFA supplementation is generally well-tolerated, but some supplements and clinical situations require caution.
  • Current evidence suggests PUFA supplementation may be a promising therapeutic approach for MS.

Conclusions:

  • Further large-scale clinical trials are necessary to confirm the benefits of PUFA supplementation in multiple sclerosis.
  • Clinicians should be informed about the nuances of PUFA supplementation, including potential risks and benefits.